Team:Braunschweig/Notebook

From 2013.igem.org

(Difference between revisions)
 
(105 intermediate revisions not shown)
Line 14: Line 14:
margin-left: 45px;
margin-left: 45px;
margin-right: 65px;
margin-right: 65px;
-
margin-top: 100px;
+
margin-top: 75px;
}
}
 +
 +
a:link { text-decoration:none; color:#be1e3c; }
 +
a:visited { text-decoration:none; color:#be1e3c;}
 +
a:hover { text-decoration:none;}
 +
a:active { text-decoration:none;}
 +
a:focus { text-decoration:none;}
/* Laborjournal Weeks */
/* Laborjournal Weeks */
Line 60: Line 66:
}  
}  
-
 
+
a:link { text-decoration:none; color:#be1e3c; }
 +
a:visited { text-decoration:none; }
 +
a:hover { text-decoration:none;}
 +
a:active { text-decoration:none;}
 +
a:focus { text-decoration:none;}
Line 72: Line 82:
<p><img alt="linie rot 8pix hoch" src="https://static.igem.org/mediawiki/2013/0/07/Team_Braunschweig_Red_line.jpg" width="850" height="1" /></p>
<p><img alt="linie rot 8pix hoch" src="https://static.igem.org/mediawiki/2013/0/07/Team_Braunschweig_Red_line.jpg" width="850" height="1" /></p>
-
<p>This is the documentation of our lab work. An overview on how we approached this project can be found under <a href="https://2013.igem.org/Team:Braunschweig/Project/Appoach">Approach</a>. For detailed protocols of certain procedures please refer to <a href="https://2013.igem.org/Team:Braunschweig/Protocols">Protocols</a>. Attributions are given for each day, however please check our <a href="https://2013.igem.org/Team:Braunschweig/Attributions">Attributions section</a> for efforts beyond the lab work.</p>
+
<p><img alt="Braunschweig Labbook" src="https://static.igem.org/mediawiki/2013/c/ca/Braunschweig2013_Laboratory_notebook.jpg" height="250px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
 +
This is the documentation of our lab work. Achievements of each week are summerized followed by a daily discription of our experiments.<br><br>
 +
An overview on how we approached this project can be found under <b><a href="https://2013.igem.org/Team:Braunschweig/Project/Appoach">Approach</a></b>.
 +
For detailed protocols of certain procedures please refer to <b><a href="https://2013.igem.org/Team:Braunschweig/Protocols">Protocols</a></b>. Attributions are given for each day, however please check our<br> <b><a href="https://2013.igem.org/Team:Braunschweig/Attributions">Attributions section</a></b> for efforts beyond the lab work.</p>
 +
<p><br><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<div class="weeks">
<div class="weeks">
Line 142: Line 156:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Tabea, Jan, Laura</b><br>
<b>Investigators: Tabea, Jan, Laura</b><br>
-
The distribution kit arrived!<br>
+
The distribution kit arrived!<br> <img alt="Kit" src="https://static.igem.org/mediawiki/2013/5/52/Braunschweig_Lab_Distribution_Kit.jpg" width="300" align="center" vspace="0" hspace="10"/><br><br>
We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and transformed each BioBrick. This is the full list of BioBricks we planned on using in our project:<br>
We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and transformed each BioBrick. This is the full list of BioBricks we planned on using in our project:<br>
<img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/>
<img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/>
Line 194: Line 208:
<div id="Week3" class="menuSection">
<div id="Week3" class="menuSection">
     <h2><a href="#Week3">Week 3: June 2 - June 8, 2013</a></h2>
     <h2><a href="#Week3">Week 3: June 2 - June 8, 2013</a></h2>
-
     <p style=" margin-left:5px; margin-right:5px;">This week we successfully cloned and transformed some of our first combination Bricks. We also managed to obtain some BioBricks that could not be transformed via Phusion-PCR directly from resuspended DNA.</p>
+
     <p style=" margin-left:5px; margin-right:5px;">
 +
<img alt="Transformation" src="https://static.igem.org/mediawiki/2013/f/f5/Braunschweig_Lab_Week3_Transformation.jpg" width="250" align="left" vspace="0" hspace="20"style="margin-right:5px"/>
 +
 
 +
This week we successfully cloned and transformed some of our first combination Bricks. We also managed to obtain some BioBricks that could not be transformed via Phusion-PCR directly from resuspended DNA.</p>
Line 203: Line 220:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Roman, Laura</b><br>
<b>Investigators: Roman, Laura</b><br>
-
Since the transformations of the BioBricks B0010, C0060, C0061, C0062, C0070, J23100 and J23106 were not successful, These Bricks were amplified via Phusion-PCR directly from the resuspended DNA from the distribution kit instead.<br>
+
Since the transformations of the BioBricks B0010, C0060, C0061, C0062, C0070, J23100 and J23106 were not successful, these Bricks were amplified via Phusion-PCR directly from the resuspended DNA from the distribution kit instead.<br>
We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in 2xYT medium containing respective antibiotics in order to miniprep the plasmid DNA tomorrow.</p>
We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in 2xYT medium containing respective antibiotics in order to miniprep the plasmid DNA tomorrow.</p>
Line 328: Line 345:
Today we received the NEB iGEM Support Kit. This will keep the labwork rolling ;-)<br>
Today we received the NEB iGEM Support Kit. This will keep the labwork rolling ;-)<br>
Yesterday’s colony PCR(E0420 and C0061+B0015) was analyzed on a 1% agarose gel.The amplified fragment for E0420 matched the expected fragment size of 1192 bp. The PCR for C0061+B0015 failed. A faint PCR product of 6-7kb could be detected for clone 2 indicating (again) an additional oligonucleotide sequence 5’ of the BioBrick. This additional DNA sequence may have up to 6kb. We isolated the plasmid DNA from all clones of E0420 and C0061 + B0015 with a miniprep kit following the manufacturer’s instructions to send them to GATC.<br>
Yesterday’s colony PCR(E0420 and C0061+B0015) was analyzed on a 1% agarose gel.The amplified fragment for E0420 matched the expected fragment size of 1192 bp. The PCR for C0061+B0015 failed. A faint PCR product of 6-7kb could be detected for clone 2 indicating (again) an additional oligonucleotide sequence 5’ of the BioBrick. This additional DNA sequence may have up to 6kb. We isolated the plasmid DNA from all clones of E0420 and C0061 + B0015 with a miniprep kit following the manufacturer’s instructions to send them to GATC.<br>
-
In order to clone the inducible promoters P<sub>lux</sub> (R0062), P<sub>rhl</sub> (R0071) and P<sub>las</sub> (K091117) 5’ of the RBS (B0032), we digested them with EcoRI and SpeI. At the same time the lactonase (C0060) and lactonase + TT were digested with XbaI and PstI to clone them 3’ of a RBS. The autoinducer synthases + TT (C0078+B0015, C0070+B0015, C0061+B0015) were digested with XbaI and PstI for cloning. Also we did a test restriction of C0061 since the DNA sequence indicated it contained an additional nucleotide sequence.<br><br><br>
+
In order to clone the inducible promoters Plux (R0062), Prhl (R0071) and Plas (K091117) 5’ of the RBS (B0032), we digested them with EcoRI and SpeI. At the same time the lactonase (C0060) and lactonase + TT were digested with XbaI and PstI to clone them 3’ of a RBS. The autoinducer synthases + TT (C0078+B0015, C0070+B0015, C0061+B0015) were digested with XbaI and PstI for cloning. Also we did a test restriction of C0061 since the DNA sequence indicated it contained an additional nucleotide sequence.<br><br><br>
<img alt="June13" src="https://static.igem.org/mediawiki/2013/3/30/Braunschweig_Lab_Journal_June_13_2.png" width="200" align="right" vspace="0" hspace="10"/>
<img alt="June13" src="https://static.igem.org/mediawiki/2013/3/30/Braunschweig_Lab_Journal_June_13_2.png" width="200" align="right" vspace="0" hspace="10"/>
The expected fragments of the promoters are 82, 80 and 153 bp.  We were not able to detect the fragments on the agarose gel. The restriction digest of C0060, C0078+B0015 and C0070+B0015 was not complete. However, the fragments matched the expected sizes, so they were extracted from the agarose gel.<br>
The expected fragments of the promoters are 82, 80 and 153 bp.  We were not able to detect the fragments on the agarose gel. The restriction digest of C0060, C0078+B0015 and C0070+B0015 was not complete. However, the fragments matched the expected sizes, so they were extracted from the agarose gel.<br>
Line 377: Line 394:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Roman, Laura, Kerstin</b><br>
<b>Investigators: Roman, Laura, Kerstin</b><br>
 +
<img alt="June24" src="https://static.igem.org/mediawiki/2013/0/01/Braunschweig_Lab_Journal_June_24_4.png" align="right" height="200px"  vspace="0" hspace="0"/>
In order to harvest the successfully ligated bricks, DNA  of liquid cultures from positively tested clones was prepared for sequencing.
In order to harvest the successfully ligated bricks, DNA  of liquid cultures from positively tested clones was prepared for sequencing.
We also repeated the colony PCR of the last four ligations as they showed questionable restriction patterns.
We also repeated the colony PCR of the last four ligations as they showed questionable restriction patterns.
Line 430: Line 448:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Roman, Laura </b><br>
<b>Investigators: Roman, Laura </b><br>
-
<img alt="June24" src="https://static.igem.org/mediawiki/2013/0/01/Braunschweig_Lab_Journal_June_24_4.png" align="right" height="140px"  vspace="0" hspace="10"/>Yesterday’s colony PCR of B0032-C0061-B0015 unfortunately was negative for all ten clones, as can be seen on the gel. Roman made minipreps of J23100-B0032-C0071/C0079 and B0032-C0070/C0078-B0015. These parts and furthermore C0061 and C0062 were prepared and sent to be sequenced. Since purification of ligated <i>ampR</i> in a column was not successful we tried to obtain it by gel extraction. The ligations of R0071-B0032-<i>ampR</i>, R0062-B0032-<i>ampR</i> and K091117-B0032-<i>ampR</i> were successful as indicated by colony PCR, therefore we inoculated cultures with bacteria carrying this construct for further processing.</p>
+
Yesterday’s colony PCR of B0032-C0061-B0015 unfortunately was negative for all ten clones, as can be seen on the gel. Roman made minipreps of J23100-B0032-C0071/C0079 and B0032-C0070/C0078-B0015. These parts and furthermore C0061 and C0062 were prepared and sent to be sequenced. Since purification of ligated <i>ampR</i> in a column was not successful we tried to obtain it by gel extraction. The ligations of R0071-B0032-<i>ampR</i>, R0062-B0032-<i>ampR</i> and K091117-B0032-<i>ampR</i> were successful as indicated by colony PCR, therefore we inoculated cultures with bacteria carrying this construct for further processing.</p>
<p><img alt="June24" src="https://static.igem.org/mediawiki/2013/d/db/Braunschweig_Lab_Journal_June_24.png" height="140px"  vspace="0" hspace="10"/>
<p><img alt="June24" src="https://static.igem.org/mediawiki/2013/d/db/Braunschweig_Lab_Journal_June_24.png" height="140px"  vspace="0" hspace="10"/>
<img alt="June24" src="https://static.igem.org/mediawiki/2013/0/0f/Braunschweig_Lab_Journal_June_24_2.png" height="140px"  vspace="0" hspace="10"/>
<img alt="June24" src="https://static.igem.org/mediawiki/2013/0/0f/Braunschweig_Lab_Journal_June_24_2.png" height="140px"  vspace="0" hspace="10"/>
Line 438: Line 456:
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 25, 2013</p>
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 25, 2013</p>
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
-
<b>Investigators: Jan, Kerstin </b><br>
+
<b>Investigator: Jan, Kerstin</b><br>
-
We made minipreps and Glycerin stocks of R0071/R0062/K091117-B0032-<i>ampR</i>. For validation of K091117’s sequence (2 basepairs differed from the sequence given in the registry) Kerstin conducted another Phusion-PCR. After ligation the product was evaluated by colony PCR. Together with R0071/R0062/K091117-B0032-<i>ampR</i>, K091117 was prepared and sent for sequencing. K091117-B0032-<i>ampR</i> was a double clone. We also took soil samples for the iGEM Team Norwich.</p>
+
<img alt="Soil samples" src="https://static.igem.org/mediawiki/2013/e/ea/Braunschweig_Lab_Week6_Bodenproben.jpg" height="140px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
 +
We made minipreps and glycerol stocks of R0071/R0062/K091117-B0032-<i>ampR</i>. For validation of K091117’s sequence (2 basepairs differed from the sequence given in the registry) Kerstin conducted another Phusion-PCR. After ligation the product was evaluated by colony PCR. Together with R0071/R0062/K091117-B0032-<i>ampR</i>, K091117 was prepared and sent for sequencing. K091117-B0032-<i>ampR</i> was a double clone.<br>
 +
We also took soil samples for the iGEM Team Norwich.
 +
</p>
 +
 
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 474: Line 497:
<b>Investigators: Kerstin, Laura </b><br>
<b>Investigators: Kerstin, Laura </b><br>
Yesterday's ligations transformed into <i>E. coli</i> XL1 MRF' by heatshock and plated on 2xYT agar containing glucose and Chloramphenicol.<br>  
Yesterday's ligations transformed into <i>E. coli</i> XL1 MRF' by heatshock and plated on 2xYT agar containing glucose and Chloramphenicol.<br>  
-
Since the chromoprotein DNA from Uppsala iGEM Team 2011 arrived today we now switched to our new cloning strategy starting with resuspending and transforming the newly arrived DNA into <i>E. coli</i> XL1 Blue MFR' by heatshock. Cells were as well plated on 2xYT agar containing glucose and chloramphenicol.<br>
+
Since the chromoprotein DNA from Uppsala iGEM Team 2011 arrived today we now switched to our new cloning strategy starting with resuspending and transforming the newly arrived DNA into <i>E. coli</i> XL1 Blue MFR' by heatshock. Cells were as well plated on 2xYT agar containing glucose and chloramphenicol.<p>
-
Even if we switched to our new strategy we still kept working on the fluorescence markers. Therefore we digested the BioBricks E0420 (eCFP), E0430 (YFP) and J06702 (mCherry) as well as our promotor-RBS-LasR and promotor-RBS-RhlR-constructs. Still lacking the construct containing LuxR we decided to proceed with the promotor-RBS-construct instead to ligate it to the YFP-Brick. Gel extraction was performed for the inserts and DNA purification for the vector parts. Inserts and bricks were ligated overnight using T4 DNA ligase (NEB) at 16°C.<br><br>
+
<p><img alt="Chromoprotein arrival" src="https://static.igem.org/mediawiki/2013/2/2e/Braunschweig_Lab_Week7_Chromoproteina_arrival.jpg" height="150px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
-
Since we now have our first constructs containing the inducible promotors as well as the the ampicillin resistence gen we started our first leakiness experiments. All constructs (P<sub>las</sub>, P<sub>rhl</sub>, P<sub>lux</sub> in combination with the RBS and <i>ampR</i>) were cultivated overnight in 2xYT medium containing various ampicillin concentrations.</p>
+
Even if we switched to our new strategy we still kept working on the fluorescence markers. Therefore we digested the BioBricks E0420 (eCFP), E0430 (YFP) and J06702 (mCherry) as well as our promotor-RBS-LasR and promotor-RBS-RhlR-constructs. Still lacking the construct containing LuxR we decided to proceed with the promotor-RBS-construct instead to ligate it to the YFP-Brick. Gel extraction was performed for the inserts and DNA purification for the vector parts. Inserts and bricks were ligated overnight using T4 DNA ligase (NEB) at 16°C.<br><br><br>
 +
Since we now have our first constructs containing the inducible promotors as well as the the ampicillin resistence gen we started our first leakiness experiments. All constructs (Plas, Prhl, Plux in combination with the RBS and <i>ampR</i>) were cultivated overnight in 2xYT medium containing various ampicillin concentrations.</p>
Line 485: Line 509:
<b>Investigators: Laura, Kerstin </b><br>
<b>Investigators: Laura, Kerstin </b><br>
Before we started working on our own chromoprotein-constructs, we screened for the optimum cultivation conditions. We cultivated <i>E. coli</i> XL1 Blue MRF' containing a new construct from Uppsala iGEM encoding the device J23110-B0034-aeBlue. We tested expression of the blue chromoprotein at different temperatures, oxygen supply and rpm. These experiments led to the conclusion that low oxygen supply and a temperature of 37°C result in higher expression rates.<br><br>
Before we started working on our own chromoprotein-constructs, we screened for the optimum cultivation conditions. We cultivated <i>E. coli</i> XL1 Blue MRF' containing a new construct from Uppsala iGEM encoding the device J23110-B0034-aeBlue. We tested expression of the blue chromoprotein at different temperatures, oxygen supply and rpm. These experiments led to the conclusion that low oxygen supply and a temperature of 37°C result in higher expression rates.<br><br>
-
The evaluation of the leakiness of the inducible promotors showed that only the P<sub>rhl</sub> is not leaky. P<sub>lux</sub> as well as P<sub>las</sub> were leaky and showed growth of <i>E. coli</i> XL1 Blue MRF' at all tested ampicillin concentrations. Therefore we repeated the experiment using higher ampicillin conentrations.<br><br>
+
The evaluation of the leakiness of the inducible promotors showed that only the Prhl is not leaky. Plux as well as Plas were leaky and showed growth of <i>E. coli</i> XL1 Blue MRF' at all tested ampicillin concentrations. Therefore we repeated the experiment using higher ampicillin conentrations.<br><br>
The bricks containing the fluorescencw markers ligated yesterday were transformed in <i>E. coli</i> XL1 Blue MRF' by heatshock.<br><br>
The bricks containing the fluorescencw markers ligated yesterday were transformed in <i>E. coli</i> XL1 Blue MRF' by heatshock.<br><br>
<img alt="July3" src="https://static.igem.org/mediawiki/2013/f/fa/Braunschweig_Lab_Journal_July_3.png" width="200" align="right" vspace="0" hspace="10"/>Colony PCR of the constructs containing lactonase and LuxI which were transformed yesterday was performed. Since all screened colonies showed religated vectors we decided to try an alternative restriction strategy to combine the BioBricks by using the endonuclease NcoI.<br>   
<img alt="July3" src="https://static.igem.org/mediawiki/2013/f/fa/Braunschweig_Lab_Journal_July_3.png" width="200" align="right" vspace="0" hspace="10"/>Colony PCR of the constructs containing lactonase and LuxI which were transformed yesterday was performed. Since all screened colonies showed religated vectors we decided to try an alternative restriction strategy to combine the BioBricks by using the endonuclease NcoI.<br>   
Line 511: Line 535:
<b>Investigators: Kerstin, Laura, Jan </b><br>
<b>Investigators: Kerstin, Laura, Jan </b><br>
When we checked the agar plates for transformed colonies with the LuxI and lactonase containing constructs we did not have any colonies.<br>  
When we checked the agar plates for transformed colonies with the LuxI and lactonase containing constructs we did not have any colonies.<br>  
-
The digested chromoprotein DNA was ligated with the RBS and the promotor-RBS construct at room temperature for 30 minutes. The ligated DNA was transformed in <i>E. coli</i> XL1 Blue MRF' by heatshock and plated on agar plates. We cannot wait to see colorful colonies on Sunday :-)<br><br>
+
The digested chromoprotein DNA was ligated with the RBS and the promotor-RBS construct at room temperature for 30 minutes. The ligated DNA was transformed in <i>E. coli</i> XL1 Blue MRF' by heatshock and plated on agar plates. We cannot wait to see colorful colonies on Sunday :-)<br>
Since we almost ran out off our competent cells it was time for new ones. New compentent cells were made and transformation efficiency was tested.<br>
Since we almost ran out off our competent cells it was time for new ones. New compentent cells were made and transformation efficiency was tested.<br>
-
A new idea to cope with the leakiness of the P<sub>las</sub> and P<sub>lux</sub> was to try a different antibiotic which cannot be metabolised. We used carbenicillin instead of ampicillin at different concentrations in liquid culture with 2xYT medium. Unfortunatly no effect could be observed on the leakyness of both inducible promotors.</p>   
+
A new idea to cope with the leakiness of the Plas and Prhl was to try a different antibiotic which cannot be metabolised. We used carbenicillin instead of ampicillin at different concentrations in liquid culture with 2xYT medium. Unfortunatly no effect could be observed on the leakyness of both inducible promotors.</p>   
   </div>
   </div>
Line 519: Line 543:
<div id="Week8" class="menuSection">
<div id="Week8" class="menuSection">
     <h2><a href="#Week8">Week 8: July 7 - July 13, 2013</a></h2>
     <h2><a href="#Week8">Week 8: July 7 - July 13, 2013</a></h2>
-
     <p style=" margin-left:5px; margin-right:5px;">Week 8</p>
+
     <p><p style=" margin-left:5px; margin-right:5px;">
 +
<p><img alt="Chromoprotein expression" src="https://static.igem.org/mediawiki/2013/f/fb/Braunschweig_Lab_expressed_chromoproteins.png" height="140px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
 +
This week we cultivated  the chromoprotein expression cassetts for the first time in liquid culture. It was a great motivation to observe our constructs to work as expected. Everyone is really excited about the colorful cultures! <br> The leakiness problem we still try to get rid of is less motivating but we still did not give up trying to find a solution this week.<p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, July 7, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Laura</b><br>
 +
Today, 2xYT liquid cultures were inoculated with colonies of <i>E. coli</i> XL1 Blue MRF' transformed with the constructs containing the blue, red and yellow chromoproteins (aeBlue, eforRed and amilGFP respectively) controlled by constitutive promoters (J23100) and equipped with a ribosome binding site (B0032). Cultures are grown overnight at 37°C and 250 rpm</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, July 8, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Kerstin, Laura</b><br>
 +
As the cultures were prepared yesterday, plasmid DNA containing the chromoprotein expression cassettes were minipreped and glyercol cell stocks of cells were prepared.
 +
Also, transformations of the ligated DNA of lactonase expression cassette and Lux  autoinducer synthase LuxI (C0061) flanked by a ribosome binding (B0032) site and a double terminator (B0015) in <i>E. coli</i> XL1 Blue MRF' were performed by heat shock.
 +
Last Friday we observed that there is no effect on the leakiness of the inducible promoters by using carbenicillin as a selection marker. We assumed that there was a contamination either in the medium or the glycerol sotck, so we repeated the leakiness tests with tetracycline and ampicillin insteadt in 2xYT liquid cultures overnight.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday 9, July 17, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Laura, Kerstin, Kevin</b><br>
 +
The results of the leakiness experiment: The growth of cells equipped with the Plas inducible ampicillin resistance cassette, probably a double clone, was firstly limited at ampicillin concentration of 400µg/ml. The Plas inducible ampicillin resistance cassette and the positive control grew at all tested concentrations of ampicillin (100µg/ml-1 mg/ml).
 +
To show that the transformation of our chromoprotein expression cassettes with and without strong constitutive promoters was successful, colony PCR was performed.
 +
The constitutive RhlR and LasR transcription factor expression cassettes were digested with  appropriate restriction enzymes and desired fragments were extracted from gel after gelelectrophoresis. Lastly, the DNA was purified. Transformation of the Plas inducible ampicillin resistance cassette was performed. However, after prepping the DNA and sending it for sequencing the sequence revealed that this construct was a double clone.
 +
The earlier mentioned transcription factor expression cassettes for RhlR and LasR were then ligated and incubated overnight. Also, 2xYT liquid cultures of all chromoprotein expression cassettes were prepared and incubated overnight.</p>
 +
 
 +
 
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, July 10, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Melanie, Laura, Kerstin</b><br>
 +
Today, we transformed the ligated DNA of our transcription factors RhlR and LasR expression cassettes (containing strong constitutive promoter, RBS and double terminator) into <i>E. coli</i> XL1 Blue MRF' by heat shock and plated the samples on 2xYT agar containing chloramphenicol. The colony PCR with GoTaq of these ligations did not show fragments of expected size for any of the selected clones.
 +
All chromoprotein containing constructs (expression cassettes as well as chromoprotein encoding genes combined with RBS) were minipreped and sent for sequencing.
 +
Digestion of our trouble-makingautoinducer synthase LuxI and  transcription factor LuxR cassettes was done with endonuclease NcoI as an alternative to standard restriction enzymes. As a next step the DNA was ligated and transformed into <i>E.Coli</i> XL1 Blue MRF'. Extraction of DNA from gel was only performed for the ribosome binding site (B0032).
 +
Furthermore, we digested the chromoprotein expression parts for aeBlue and eforRed, ran a gel electrophoresis, extracted desired fragments from the gel and subsequently purified the DNA.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, July 11, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Anna, Kevin</b><br>
 +
Today, we ligated the extracted and purified DNA of our constitutive chromoprotein expression cassettes encoding aeBlue and eforRed. The products were our combined constructs of Las- or Rhl-autoinducer synthase LasI and RhlI and constitutive eforRed chromoprotein and aeBlue expression cassettes respectively.
 +
A PCR of the terminator (B0015) was performed with Q5 polymerase in order to gain more DNA material for digestion and ligation.
 +
The ligations of our combined constructs of autoinducer synthases LasI (flanked by RBS and double terminator) and constitutive eforRed expression cassette as well as RhlI (flanked by RBS and double terminator) and constitutive aeBlue expression cassette and the LuxR transcription factor expression cassette were transformed into <i>E. coli</i> XL1 Blue MRF'.
 +
The last action for today was to inoculate an overnight liquid culture of our ampicillin resistance cassettes equipped with either Rhl-, Lux- or Las-dependent promoter  in LB Medium with different ampicillin concentrations (100 µg/ml, 250 µg/ml, 500 µg/ml and 1 mg/ml) to test for potential leakiness in a different medium. Cultures were grown overnight at 37°C and 250 rpm.<p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, July 12, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Kerstin, Laura</b><br>
 +
Today, our aim was to combine the chromoprotein expression cassettes with the double terminator (B0015). Thus, the chromoprotein expression cassettes were digested, a gel electrophoresis was run and insert fragments were extracted from gel while the vector part was dephosphorylated. Afterwards purification of vector and insert parts was performed and the DNA was ligated according to our protocol. Subsequently, the ligated DNA was transformed into <i>E. coli</i> XL1 Blue MRF' by heat shock.
 +
Yesterday‘s test for leakiness under different conditions showed that the use of LB Medium wouldn’t solve the problem of the leaky promoters since liquid cultures showed high cell density for all ampicillin concentrations. We still need to find a solution for this problem in order to get our concept to work.
 +
Furthermore, we performed new colony PCRs and agarose ge of the transcription factor LuxR, the combined Rhl-autoinducer synthase RhlI and aeBlue expression cassette as well as the Plas induced ampicillin resistance cassette from colonies on agar plates.<p>  
   </div>
   </div>
Line 525: Line 608:
     <h2><a href="#Week9">Week 9: July 14 - July 20, 2013</a></h2>
     <h2><a href="#Week9">Week 9: July 14 - July 20, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
The highlight of this week was our first visit at the DSMZ (German collection of microorganisms an cell cultures). We got the chance to analyze our cells containing different chromoprotein expression cassettes with a fluorescent activated cell sorter and found out that it is difficult to differentiate our cells them like this.</p>
+
The highlight of this week was our first visit at the DSMZ (German collection of microorganisms an cell cultures). We got the chance to analyze our cells containing different chromoprotein expression cassettes with a FACS (Fluorescent Activated Cell Sorter) and found out that it is difficult to differentiate our cells them like this.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 532: Line 615:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Anna, Kerstin, Laura, Melanie</b><br>
<b>Investigators: Kevin, Anna, Kerstin, Laura, Melanie</b><br>
-
In order to construct  the rhlR and lasR expression cassettes with an upstream double terminator, both expression cassettes and the double terminator were restricted and extracted from gel and purified respectively. After ligation a transformation was performed.
+
In order to construct  the RhlR and LasR expression cassettes with an upstream double terminator both expression cassettes and the double terminator were restricted and extracted from gel and purified respectively. After ligation a transformation was performed.
-
Furthermore the problem with the leakiness of our promoters was discussed again. Therefore we tested the expression cassettes containing the inducible promoters in different minimal media. We observed leakiness for the inducible promoter of the las quorum sensing system, but not leakiness for the inducible promoter from the rhl quorum sensing system. Thus the minimal media did not solve our problems with the promoter leakiness.
+
Furthermore the problem with the leakiness of our promoters was discussed again. Therefore we tested the expression cassettes containing the inducible promoters in different minimal media. We observed leakiness for the inducible promoter of the las quorum sensing system, but no leakiness for the inducible promoter from the rhl quorum sensing system. Thus, the minimal media did not solve our problems with the promoter leakiness.
-
In the afternoon Kerstin, Laura, Anna and Melanie visited the DSMZ in Braunschweig  and tested the fluorescence characteristica of cells carrying a single chromoprotein and mixtures of cell carrying different chromoproteins in a fluorescent associated cell sorter. When measuring cells containing the same chromoprotein we saw that it might be possible to differentiate cells carrying the yellow amilGFP and the red eforRed chromoprotein. But when we measured mixed cultures no differentiation was possible without an obvious reason. A few days later when we saw a mixture of the cells under the microscope we found out that the expression of the chromoprotein may lead to stickiness of the cells, thus no differentiation and sorting of the cells in the facs is possible.
+
In the afternoon Kerstin, Laura, Anna and Melanie visited the DSMZ in Braunschweig  and tested the fluorescence characteristica of cells carrying a single chromoprotein and mixtures of cell carrying different chromoproteins in a FACS (Fluorescent Associated Cell Sorter). When measuring cells containing the same chromoprotein expression cassette we saw that it might be possible to differentiate cells carrying the yellow amilGFP and the pink eforRed chromoprotein by thier fluorescence cause they showed significantly different signals. However, when we measured mixed cultures no differentiation was possible without any obvious reason. A few days later we observed a mixture of cells under the microscope and found out that the expression of the chromoprotein may lead to stickiness of the cells causing them to build big clusters, thus unfortunately no differentiation and sorting of the cells in the FACS is possible in order to determine mixed culture composition.
-
A PCR of the inducible promoter expression cassette of the las quorum senisng system and RBS-luxI-TT device was performed.
+
Back at our lab, a PCR of the inducible promoter expression cassette of the las quorum sensing system and RBS-luxI-TT device was performed.
-
The inducible ampicillin resistance cassettes of the las und rhl qourum sensing system were transformed in Top10 F' E. coli cells to get rid of the problem with promoter leakiness.</p>
+
The inducible ampicillin resistance cassettes of the las und rhl qourum sensing system were transformed in <i>E. coli</i> Top10 F' cells to get rid of the problem with promoter leakiness.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 543: Line 626:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Melanie</b><br>
<b>Investigators: Laura, Melanie</b><br>
-
After performing PCR and gel electrophoresis of the lasR and rhl expression cassettes with an upstream double terminator no clones showed a right band size on the gel.</p>
+
<img alt="July 16" src="https://static.igem.org/mediawiki/2013/1/19/Week9-1.png" width="200px" align="right" vspace="10" hspace="10"/>
-
 
+
After performing PCR and gel electrophoresis of the LasR and RhlR expression cassettes combined with an upstream double terminator no clones showed a right band size on the gel.<br>
-
</p>
+
Minipreperation of the las expression cassette and RBS-<i>luxI</i>-TT device was carried out and prepared for sequencing.</p>
-
<p><img alt="Week9-1" src="https://static.igem.org/mediawiki/2013/e/e5/Week9-1.png" width="280px" vspace="10" hspace="10"/>
+
-
</p>
+
-
 
+
-
<p>Minipreperation of the las expression cassette and RBS-luxI-TT device was carried out and prepared for sequencing.</p>
+
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 556: Line 635:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Laura</b><br>
<b>Investigators: Kevin, Laura</b><br>
-
Once more a colony-PCR of the lasR and rhl expression cassettes with an upstream double terminator and of the three inducible promoter expression cassettes was performed.
+
<img alt="July 17" src="https://static.igem.org/mediawiki/2013/6/6f/Week9-2.png" width="200px" align="right" vspace="10" hspace="10"/> Once more a colony PCR of the LasR and RhlR expression cassettes with the combinded upstream double terminator as well as of the three inducible promoter expression cassettes was performed.
-
Furthermore liquid cultures of  mcherry, YFP and eCFP fluorescenze expression cassettes and the lasR and rhl expression cassettes with an upstream double were inoculated.  
+
Furthermore, 2xYT liquid cultures of <i>E. coli</i> XL1 Blue MRF' mCherry, YFP and eCFP fluorescence expression cassettes and the LasR and RhlR expression cassettes with an upstream double were inoculated.  
The ampicillin resistance was extracted from gel.</p>  
The ampicillin resistance was extracted from gel.</p>  
-
</p>
+
 
-
<p><img alt="Week9-2" src="https://static.igem.org/mediawiki/2013/e/e5/Week9-2.png" width="280px"  vspace="10" hspace="10"/>
+
-
</p>
+
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 569: Line 646:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Roman, Melanie</b><br>
<b>Investigators: Roman, Melanie</b><br>
-
The mcherry, YFP and eCFP fluorescenze expression cassettes and the lasR and rhl expression cassettes with an upstream double were prepped and prepared for sequencing. Glycerol stocks of every Brick were made.
+
The plasmid DNA encoding mCherry, YFP and eCFP fluorescenze expression cassettes and the LasR and RhlR expression cassettes with an upstream double were prepped from overnight cultures and prepared for sequencing. Glycerol stocks of every Brick were made.
-
For the ligation of the luxR expression cassette the promoter with RBS and the luxR gene were restricted and purified.</p>  
+
For the ligation of the LuxR expression cassette the promoter with RBS and the <i>luxR</i> gene were restricted and purified.</p>  
   </div>
   </div>
Line 577: Line 654:
     <h2><a href="#Week10">Week 10: July 21 - July 27, 2013</a></h2>
     <h2><a href="#Week10">Week 10: July 21 - July 27, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
This week we managed to construct our N-buturyl-HSL (Rhl system) inducible ampicillin resistance cassette (R0071-B0032-AmpR-B0015-J23100-B0032-C0071) and our N-3-oxododecanoyl-HSL (Las system) inducible ampicillin resistance cassette (K091117-B0032-AmpR-B0015-J23100-B0032-C0079). Furthermore, the constructs of the amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI and eforRed cassette (B0032-C0076-B0015-J23100-B0032-K592012-B0015), the N-buturyl-HSL synthase RhlI and aeBlue cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) and terminator-modified N-buturyl-HSL (Rhl system) inducible Amp-resistance cassette (B0015-R0071-B0032-AmpR-B0015-J23100-B0032-C0071) are nearly finished.
+
This week we managed to construct our N-butyryl-HSL (Rhl system) inducible ampicillin resistance cassette (R0071-B0032-AmpR-B0015-J23100-B0032-C0071) and our N-3-oxododecanoyl-HSL (Las system) inducible ampicillin resistance cassette (K091117-B0032-AmpR-B0015-J23100-B0032-C0079). Furthermore, the constructs of the amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI and eforRed cassette (B0032-C0076-B0015-J23100-B0032-K592012-B0015), the N-butyryl-HSL synthase RhlI and aeBlue cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) and terminator-modified N-butyryl-HSL (Rhl system) inducible Amp-resistance cassette (B0015-R0071-B0032-AmpR-B0015-J23100-B0032-C0071) are nearly finished.
Additionally we started our first test runs with the new chromoproteins.</p>
Additionally we started our first test runs with the new chromoproteins.</p>
Line 585: Line 662:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Kerstin, Laura</b><br>
<b>Investigators: Kevin, Kerstin, Laura</b><br>
-
We digested the N-buturyl-HSL/RhlR induced ampicillin resistance cassette (R0071-B0032-<i>ampR</i>) , the Rhl transcription factor (RhlR) cassette (B0015-J23100)-B0032-C0071), the N-3-oxododecanoyl-HSL/LasR induced ampicillin resistance cassette (K091117-B0032-<i>ampR</i>) and the Las-transcription factor (LasR) cassette (B0015-J23100-B0032-C0079) to ligate them to new constructs. The N-buturyl-HSL/RhlR inducible ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) is supposed to be combined with the RhlR cassettte while the the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) is intended to be combined with the LasR expression cassette. We successfully performed a gel extraction of the RhlR cassette (B0015-J23100-B0032-C0071) and the LasR cassette (B0015-J23100-B0032-C0079). Additionally we measured the absorption spectra emission of our newly received chromoproteins.
+
We digested the N-butyryl-HSL/RhlR induced ampicillin resistance cassette (R0071-B0032-<i>ampR</i>) , the Rhl transcription factor (RhlR) cassette (B0015-J23100)-B0032-C0071), the N-3-oxododecanoyl-HSL/LasR induced ampicillin resistance cassette (K091117-B0032-<i>ampR</i>) and the Las-transcription factor (LasR) cassette (B0015-J23100-B0032-C0079) to ligate them to new constructs. The N-butyryl-HSL/RhlR inducible ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) is supposed to be combined with the RhlR cassettte while the the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) is intended to be combined with the LasR expression cassette. We successfully performed a gel extraction of the RhlR cassette (B0015-J23100-B0032-C0071) and the LasR cassette (B0015-J23100-B0032-C0079). Additionally we measured the absorption spectra emission of our newly received chromoproteins.
</p>
</p>
<p><img alt="Absorption amilGFP" src="https://static.igem.org/mediawiki/2013/e/e5/Braunschweig_Absorption-amilGFP.jpg" width="280px"  vspace="10" hspace="10"/>
<p><img alt="Absorption amilGFP" src="https://static.igem.org/mediawiki/2013/e/e5/Braunschweig_Absorption-amilGFP.jpg" width="280px"  vspace="10" hspace="10"/>
Line 597: Line 674:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin</b><br>
<b>Investigators: Kevin</b><br>
-
Today we transformed yesterday’s ligations of the N-buturyl-HSL/RhlR inducicle ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079).
+
Today we transformed yesterday’s ligations of the N-butyryl-HSL/RhlR inducicle ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079).
-
Furthermore, we inoculated overnight cultures of the <i>E. Coli</i> XL1 Blue MRF' expressing the chromoproteins for further spectrum measurements. Cultures were grown in 2xYT containing chloramphenicol at 37°C and 250 rpm overnight.</p>
+
Furthermore, we inoculated overnight cultures of the <i>E. coli</i> XL1 Blue MRF' expressing the chromoproteins for further spectrum measurements. Cultures were grown in 2xYT containing chloramphenicol at 37°C and 250 rpm overnight.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 605: Line 682:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Kerstin</b><br>
<b>Investigators: Kevin, Kerstin</b><br>
-
A colony PCR of the successfully transformed N-buturyl-HSL/RhlR inducible ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) was performed. We also extracted the chromoproteins by performing a cell disruption and measured their emission spectra.</p>
+
A colony PCR of the successfully transformed N-butyryl-HSL/RhlR inducible ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) was performed. We also extracted the chromoproteins by performing a cell disruption and measured their emission spectra.</p>
<p><img alt="Emission amilGFP" src="https://static.igem.org/mediawiki/parts/7/73/BS2013Emission_amilGFP.jpg" width="280px"  vspace="10" hspace="10"/>
<p><img alt="Emission amilGFP" src="https://static.igem.org/mediawiki/parts/7/73/BS2013Emission_amilGFP.jpg" width="280px"  vspace="10" hspace="10"/>
<img alt="Emission aeBlue" src="https://static.igem.org/mediawiki/parts/f/f6/BS2013Emission_aeBlue.jpg" width="280px"  vspace="10" hspace="10"/>
<img alt="Emission aeBlue" src="https://static.igem.org/mediawiki/parts/f/f6/BS2013Emission_aeBlue.jpg" width="280px"  vspace="10" hspace="10"/>
Line 616: Line 693:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kerstin</b><br>
<b>Investigators: Laura, Kerstin</b><br>
-
We confirmed that our N-buturyl-HSL/RhlR inducicle ampicillin resistance cassette and RhlR cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) as well as our N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette and LasR Cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were correctly ligated by gel electrophoresis. Both contructs showed PCR fragments of expected size. In order to obtain material for sequencing an overnight culture of 2xYT containing chloramphenicol was inoculated with clones bearing the right contructs.</p>
+
We confirmed that our N-butyryl-HSL/RhlR inducicle ampicillin resistance cassette and RhlR cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) as well as our N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette and LasR Cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were correctly ligated by gel electrophoresis. Both contructs showed PCR fragments of expected size. In order to obtain material for sequencing an overnight culture of 2xYT containing chloramphenicol was inoculated with clones bearing the right contructs.</p>
Line 624: Line 701:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kerstin</b><br>
<b>Investigators: Laura, Kerstin</b><br>
-
The N-buturyl-HSL/RhlR inducicle ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were minipreped for sequencing.<br>
+
The N-butyryl-HSL/RhlR inducicle ampicillin resistance cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the N-3-oxododecanoyl-HSL/LasR inducible ampicillin resistance cassette (K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were minipreped for sequencing.<br>
-
The constructs of the amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI and eforRed cassette (B0032-C0076-B0015-J23100-B0032-K592012-B0015), the N-buturyl-HSL synthase RhlI and aeBlue cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) and the terminator-modified N-buturyl-HSL/RhlR inducible ampicillin resistance cassette (B0015-R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) were digested, ligated and transformed.<br>
+
The constructs of the amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI and eforRed cassette (B0032-C0076-B0015-J23100-B0032-K592012-B0015), the N-butyryl-HSL synthase RhlI and aeBlue cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) and the terminator-modified N-butyryl-HSL/RhlR inducible ampicillin resistance cassette (B0015-R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) were digested, ligated and transformed.<br>
As we were not able to transform the pSB1C3 plasmid of BBa_B0015, we performed a Q5 PCR of the part. The fragment was extracted from a gel and purified for further use.</p>
As we were not able to transform the pSB1C3 plasmid of BBa_B0015, we performed a Q5 PCR of the part. The fragment was extracted from a gel and purified for further use.</p>
Line 640: Line 717:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kerstin, Laura</b><br>
<b>Investigators: Kerstin, Laura</b><br>
-
We transformed our inducible ampicillin resistance into a new <i>E. coli</i> strain (JM109) in order to test whether the promotor being leaky is strain specific.<br>  
+
<img alt="July 29" src="https://static.igem.org/mediawiki/2013/f/f1/Braunschweig_Lab_Journal_July_29.png" width="450"  vspace="20" align="right" style="margin-left:5px"/>We transformed our inducible ampicillin resistance into a new <i>E. coli</i> strain (JM109) in order to test whether the promotor being leaky is strain specific.<br>  
-
We performed a colony PCR to test the result of our latest cloning experiments for the amilGFP cassette (J23100-B0032-K592010-B0015), the inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079), the N-3-oxododecanoyl-HSL synthase with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) and the N-buturyl-HSL synthase with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015).<br>
+
We performed a colony PCR to test the result of our latest cloning experiments for the amilGFP cassette (J23100-B0032-K592010-B0015), the inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079), the N-3-oxododecanoyl-HSL synthase with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) and the N-butyryl-HSL synthase with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015).<br>
-
The amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) and the N-buturyl-HSL synthase RhlI with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) showed the expected bands on the gel and were prepped. The inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) was prepped as well despite a second colony PCR showing no positive results.<br>
+
The amilGFP cassette (J23100-B0032-K592010-B0015), the N-3-oxododecanoyl-HSL synthase LasI with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) and the N-butyryl-HSL synthase RhlI with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) showed the expected bands on the gel and were prepped. The inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) was prepped as well despite a second colony PCR showing no positive results.<br>
-
We also tested the inducibility of our final P<sub>Rhl</sub> construct in 2xYT liquid culture with ampicillin overnight, which showed normal growth without being induced, indicating that the promotor is still leaky.<br></p>
+
We also tested the inducibility of our final Prhl construct in 2xYT liquid culture with ampicillin overnight, which showed normal growth without being induced, indicating that the promotor is still leaky.<br></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 659: Line 736:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Roman, Kevin, Anna</b><br>
<b>Investigators: Roman, Kevin, Anna</b><br>
-
We started a restriction digest of several bricks to construct three new parts: The Inducible promoter with Rhl expression cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the LasI with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) were combined to our first complete construct (fianl P<sub>Rhl</sub> construct).<br>  
+
We started a restriction digest of several bricks to construct three new parts: The Inducible promoter with Rhl expression cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) and the LasI with eforRed reporter cassette (B0032-C0076-B0015-J23100-B0032-K592012) were combined to our first complete construct (fianl Prhl construct).<br>  
The RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) was derived from the RhlI expression cassette (B0032-C0070-B0015) and the amilGFP cassette (J23100-B0032-K592010-B0015) as the blue chromoprotein was not usable for fluorescence detection.<br>
The RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) was derived from the RhlI expression cassette (B0032-C0070-B0015) and the amilGFP cassette (J23100-B0032-K592010-B0015) as the blue chromoprotein was not usable for fluorescence detection.<br>
-
The second final construct (BBa_K1073034), which is N-3-oxododecanoyl/LasR inducible, was constructed from the inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) and the N-buturyl-HSL synthase RhlI with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015).<br>
+
The second final construct (BBa_K1073034), which is N-3-oxododecanoyl/LasR inducible, was constructed from the inducible ampicillin resistance and LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) and the N-butyryl-HSL synthase RhlI with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015).<br>
Parts E0420 and J23100 were combined as another alternative for fluorescence experiments.<br>
Parts E0420 and J23100 were combined as another alternative for fluorescence experiments.<br>
We tested the results of yesterday's cloning experiments via colony PCR. C0062 and C0061-B0015 did not show bands of expected size.</p>  
We tested the results of yesterday's cloning experiments via colony PCR. C0062 and C0061-B0015 did not show bands of expected size.</p>  
Line 677: Line 754:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Anna, Melanie</b><br>
<b>Investigators: Kevin, Anna, Melanie</b><br>
-
To test the success of the last days’ cloning experiment we conducted a colony PCR. Unfortunately all clones of both our supposed final P<sub>Rhl</sub> constructs were negative. Therefore the PCR was repeated later with new colonies.  
+
<img alt="August 2" src="https://static.igem.org/mediawiki/2013/c/cb/Braunschweig_Lab_Journal_August_2.png" width="250"  vspace="20" align="left" style="margin-right:5px"/>In order to test the success of the last days’ cloning experiment we conducted a colony PCR. Unfortunately all clones of both our supposed final Prhl constructs were negative. Therefore the PCR was repeated later with new colonies.  
-
The N-buturyl-HSL synthase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100-E0420) showed both clones bearing the correct contruct.<br>
+
The N-butyryl-HSL synthase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100-E0420) showed both clones bearing the correct construct.<br>
We also conducted a test in 5 mL 2xYT liquid cultures with different concentrations of ampicillin and autoinducers to test if our new constructs were leaky. Cells bearing the inducible ampicillin resistance and LasR transcription factor (B0015-K091117-B0032-ampR-B0015-J23100-B0032-C0079) were tested with ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the ampicillin resistance was not induced.<br>
We also conducted a test in 5 mL 2xYT liquid cultures with different concentrations of ampicillin and autoinducers to test if our new constructs were leaky. Cells bearing the inducible ampicillin resistance and LasR transcription factor (B0015-K091117-B0032-ampR-B0015-J23100-B0032-C0079) were tested with ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the ampicillin resistance was not induced.<br>
Cells carrying the inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were incubated in 2xYT medium containing ampicillin in concentrations between 1 and 2 µg/mL and additionally 5 to 50 µmol/L N-butyryl-HSL (Rhl autoinducer). As we induce the ampicillin resistance we expect some of the cultures to grow, depending on which concentration is optimal.<br>
Cells carrying the inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were incubated in 2xYT medium containing ampicillin in concentrations between 1 and 2 µg/mL and additionally 5 to 50 µmol/L N-butyryl-HSL (Rhl autoinducer). As we induce the ampicillin resistance we expect some of the cultures to grow, depending on which concentration is optimal.<br>
Line 685: Line 762:
   </div>
   </div>
-
 
Line 693: Line 769:
     <h2><a href="#Week12">Week 12: August 4 - August 10, 2013</a></h2>
     <h2><a href="#Week12">Week 12: August 4 - August 10, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
This week was overshadowed by contaminated medium interfering with our experiments. We man-aged to transform the final eforRed construct (K10730359 in <i>E. coli</i> Top10F’ as the promoto seemed to not be leaky in this strain and successfully conducted a growth curve experiment showing a different in growth between induced and non-induced cultures. We are still missing our Las-inducible aeBlue construct.</p>
+
This week was overshadowed by contaminated medium interfering with our experiments. We managed to transform the final Prhl inducible construct in <i>E. coli</i> Top10F’. As the promoter seemed to be not leaky in this strain we successfully conducted a growth curve experiment showing a difference in growth between induced and non-induced cultures. We are still missing our final Plas inducible construct.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 700: Line 776:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kevin, Anna, Melanie</b><br>
<b>Investigators: Kevin, Anna, Melanie</b><br>
-
The successful cloning of our final Rhl-inducible eforRed construct (K1073035) was finally con-firmed via colony PCR. Unfortunately the liquid cultures for the minipreps were contaminated. We decided to repeat the entire colony PCR as last PCR’s replated colonies showed almost no colora-tion.<br>
+
The successful cloning of our final Prhl inducible construct was finally confirmed via colony PCR. Unfortunately the liquid cultures for the minipreps were contaminated. We decided to repeat the entire colony PCR as last PCR’s replated colonies showed almost no coloration.<br>
-
We also adapted a new cloning strategy for our Las-inducible final aeBlue construct (K1073034) by swapping vector and insert. As we discovered later, the insert was extremely hard to recover via gel extraction because of almost identical band sizes. We still tried it and proceeded with ligation.<br>
+
We also adapted a new cloning strategy for our Plas inducible construct by swapping vector and insert. As we discovered later, the insert was extremely hard to recover via gel extraction because of almost identical band sizes. We still tried it and proceeded with ligation.<br>
-
We prepared liquid cultures for a miniprep of the final eforRed construct (K1073035), the Rhl-inducer synthase with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100- E0420). These were, again, contaminated the next day.<br>
+
We prepared liquid cultures for a miniprep of the final Prhl inducible construct, the N-butyryl-HSL synthase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100- E0420). These were, again, contaminated the next day.<br>
-
In order to find a setup where our promotors are not leaky, we conducted an experiment with liquid cultures of cells bearing the Rhl-inducible Ampicillin resistance with Rhl-transcription factor cassette (R0071-B0032-B0015-J23100-B0032-C0071) and the Las-inducible Ampicillin resistance combined with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) in which we varied the concentration of Ampicillin and the corresponding inducer. The next day these cultures were contaminated as the rest of today's experiments. This is a serious problem!<br>
+
In order to find a setup where our promotors are not leaky, we conducted an experiment with liquid cultures of cells bearing the Prhl inducible ampicillin resistance with RhlR transcription factor cassette (R0071-B0032-B0015-J23100-B0032-C0071) and the Plas inducible construct ampicillin resistance combined with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) in which we varied the concentration of ampicillin and the corresponding inducer. The next day these cultures were contaminated like the rest of today's experiments. This was a serious problem!<br>
-
In order to test if the leaky promotor is caused by the XL1 Blue MRF' strain we transformed the inducible Ampicillin resistance in <i>E. coli</i> Top10F’.</p>
+
In order to test if the leaky promotor is caused by the <i>E. coli</i> XL1 Blue MRF' strain we transformed the inducible ampicillin resistance in <i>E. coli</i> Top10F’.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 712: Line 788:
<b>Investigators: Kevin, Anna</b><br>
<b>Investigators: Kevin, Anna</b><br>
We managed to test our inducible resistances without contamination interfering with the experiment:
We managed to test our inducible resistances without contamination interfering with the experiment:
-
– Cells bearing the the Las-inducible ampicillin resistance combined with LasR transcription factor and added terminator (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were tested with Ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the Ampicillin resistance was not induced.<br>
+
– Cells bearing the the Prhl inducible ampicillin resistance combined with LasR transcription factor and added terminator (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were tested with ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the ampicillin resistance was not induced.<br>
-
– Cells carrying the Las-inducible ampicillin resistance combined with LasR transcription factor and added terminator (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were cultivated on medium containing Ampicillin supplements between 1 and 8 µg/mL and addi-tionally 10 µmol/ml N-Oxodecanoyl-homoserine lactone. As we induced the ampicillin resistance we expected some of the cultures to grow, depending on which concentration is optimal.
+
– Cells carrying the Prhl inducible ampicillin resistance combined with LasR transcription factor and added terminator (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) were cultivated on medium containing ampicillin supplements between 1 and 8 µg/mL and additionally 10 µmol/ml N-3-oxododecanoyl-homoserine lactone. As we induced the ampicillin resistance we expected some of the cultures to grow, depending on which concentration is optimal.
-
– Cells bearing the Rhl-inducible ampicillin resistance with Rhl expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were tested with Ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the ampicillin resistance was not induced.<br>
+
– Cells bearing the Prhl inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were tested with ampicillin supplements between 1 and 8 µg/mL. We expected no growth as the ampicillin resistance was not induced.<br>
-
– Cells bearing the Rhl-inducible ampicillin resistance with Rhl expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were cultivated on medium containing Ampicillin supple-ments between 1 and 8 µg/mL and additionally 10 µmol/mL N-Butyryl-homoserine lactone (Rhl inducer). As we induce the Ampicillin resistance we expect some of the cultures to grow, depending on which concentration is optimal.<br>
+
– Cells bearing the Prhl inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) were cultivated on medium containing ampicillin supplements between 1 and 8 µg/mL and additionally 10 µmol/mL N-butyryl-homoserine lactone. As we induce the ampicillin resistance we expect some of the cultures to grow, depending on which concentration is optimal.<br>
-
– Cells carrying the inducible ampicillin resistance combined with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) and the inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) respectively were grown in media supplemented with Chloramphenicol as positive control. Medi-umsupplemented with Ampecillin only and medium supplemented with each Inducer only were prepared as negative controls.<br>
+
– Cells carrying the inducible ampicillin resistance combined with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) and the inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) respectively were grown in media supplemented with chloramphenicol as positive control. Medium supplemented with ampicillin only and medium supplemented with each inducer only were prepared as negative controls.<br>
The next day all but the negative controls showed normal growth confirming that our promotor is still leaky.<br><br>
The next day all but the negative controls showed normal growth confirming that our promotor is still leaky.<br><br>
-
A colony PCR confirmed that transformation of the Las-inducible ampicillin resistance with LasR transcription factor cassette (B0015-K091117-B0032-ampR-B0015-J23100-B0032-C0079) and the Rhl-inducible ampicillin resistance with Rhl expression cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) into Top10F’ was successful.<br>
+
A colony PCR confirmed that transformation of the Plas inducible ampicillin resistance with LasR transcription factor cassette (B0015-K091117-B0032-ampR-B0015-J23100-B0032-C0079) and the Prhl inducible construct ampicillin resistance with RhlR expression cassette (R0071-B0032-<i>ampR</i>-B0015-J23100-B0032-C0071) into Top10F’ was successful.</p>
-
New liquid cultures for prepping the final eforRed construct (K1073035), the Rhl-inducer synthase with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100-E0420) in TOP10F’ and XL1 BlueMRF’ were inoculated. </p>
+
<p><img alt="August 6" src="https://static.igem.org/mediawiki/2013/c/ca/Braunschweig_Lab_Journal_August_6.png" width="600"  vspace="20" align="center"/></p>
 +
 
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">New liquid cultures for prepping the final Prhl inducible construct (K1073035), the N-butyryl-HSL synthase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) and the eCFP cassette (J23100-E0420) in <i>E. coli</i> TOP10F’ and <i>E. coli</i> XL1 BlueMRF' were inoculated. </p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 728: Line 806:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan, Kevin, Laura</b><br>
<b>Investigators: Jan, Kevin, Laura</b><br>
-
We retried to clone the final aeBlue construct (K1073034) and added a new construct to our list as an alternative to the final eforRed construct (K1073035) because the blue chromoprotein is not usa-ble for our planned fluorescence experiments.
+
We retried to clone the final Plas inducible construct containing the aeBlue chromoprotein and added a new construct to our list as an alternative to the final Prhl inducible construct containing the eforRed chromoprotein because the aeBlue chromoprotein is not usable for our planned fluorescence experiments.
-
The final aeBlue construct (K1073034) was derived from the Rhl-synthase with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) (vector) and the Las-inducible ampicillin resistance with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) (insert).
+
The final Plas inducible construct was derived from the N-butyryl-HSL synthetase RhlI with aeBlue reporter cassette (B0032-C0070-B0015-J23100-B0032-K864401-B0015) (vector) and the Plas inducible ampicillin resistance with LasR transcription factor cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) (insert).
-
The final Las-inducible construct with amilGFP reporter (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015) was derived from the Rhl-inducer synthase with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) (vector) and the Las-inducible ampicillin resistance with LasR transcrip-tion factor (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) (insert).<br><br>
+
The final Plas inducible construct with amilGFP reporter (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015) was derived from the N-butyryl-HSL synthetase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) (vector) and the Las-inducible ampicillin resistance with LasR transcrip-tion factor (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079) (insert).<br><br>
-
To test whether our promotor is still leaky in Top10F’ we cultivated our newly transformed strains (in 2xYT medium supplemented with 1 µg/mL Ampicillin. Normal growth in all cultures showed that the promotor is leaky in this strain as well.<br><br>
+
To test whether our promotor is still leaky in <i>E. coli</i> Top10F' we cultivated our newly transformed strains in 2xYT medium supplemented with 1 µg/mL ampicillin. Normal growth in all cultures showed that the promotor is leaky in this strain as well.<br><br>
-
We send our freshly prepped bricks to GATC for sequencing. As a result K1073035 was contami-nated. 
+
We send our freshly prepped bricks for sequencing. As a result the sequences of the final Prhl the N-butyryl-HSL synthetase RhlI with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) was confirmed, but the prepped DNA were contaminated.  <br>  
-
The sequence of the Rhl-synthase with amilGFP reporter cassette (B0032-C0070-B0015-J23100-B0032-K592010-B0015) was confirmed, but the prepped DNA was contaminated.  <br>
+
The sequence of the eCFP cassette (J23100-E0420) was confirmed, but the prepped DNA was also contaminated as well as the DNA of the Plas inducible ampicillin resistance with RhlR expression cassette (R0071-B0032-B0015-J23100-B0032-C0071).  </p>
-
The sequence of the eCFP cassette (J23100-E0420) was confirmed, but the prepped DNA was con-taminated. 
+
-
The DNA of the Rhl-inducible ampicillin resistance with Rhl expression cassette (R0071-B0032-B0015-J23100-B0032-C0071) was contaminated.  </p>
+
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 744: Line 820:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kerstin, Laura</b><br>
<b>Investigators: Kerstin, Laura</b><br>
-
A colony PCR showed the expected bands for the final aeBlue construct (K1073034) and the final Las-inducible construct with amilGFP reporter (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015). Hopefully our final constructs are ready to use. The clones were prepped for sequencing.</p>
+
<img alt="August 8" src="https://static.igem.org/mediawiki/2013/c/cb/Braunschweig_Lab_Journal_August_8.png" width="400"  vspace="20" align="right"/>A colony PCR showed the expected bands for the final Plas inducible construct (K1073034) and the final Plas inducible construct with amilGFP reporter (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015). Hopefully our final constructs are ready to use now. The clones were prepped for sequencing.</p>
 +
 
 +
 
    
    
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 751: Line 829:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kerstin, Laura</b><br>
<b>Investigators: Kerstin, Laura</b><br>
-
The final eforRed construct (K1073035) was retransformed into <i>E. coli</i> Top10F’.<br>
+
The final Prhl inducible construct (K1073035) was retransformed into <i>E. coli</i> Top10F'.<br>
-
The prepped DNA of the final aeBlue construct (K1073034) and the Las-inducible amilGFP cas-sette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015) was sequenced. While the sequence of the Las-inducible amilGFP cassette could not be verified, the sequence of the final aeBlue construct was finally verified!<br>
+
The prepped DNA of the final Plas inducible construct (K1073034) and the Plas inducible amilGFP cassette (B0015-K091117-B0032-<i>ampR</i>-B0015-J23100-B0032-C0079-B0032-C0070-B0015-J23100-B0032-K592010-B0015) was sequenced. While the sequence of the Plas inducible amilGFP cassette could not be verified, the sequence of the final Plas inducible construct containing aeBlue expression cassette was finally verified!<br>
-
We prepared liquid cultures of the final eforRed construct (K1073035) in different E. coli strains (XL1 Blue MRF’, Top10F’) for a growth curve experiment.</p>
+
We prepared liquid cultures of the final Prhl construct (K1073035) in different <i>E. coli</i> strains (XL1 Blue MRF’, Top10F') for a growth curve experiment.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
-
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Saturday, August 8, 2013</p>
+
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Saturday, August 10, 2013</p>
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kerstin, Laura</b><br>
<b>Investigators: Kerstin, Laura</b><br>
-
Some of the liquid culture was used for prepping and sequencing the Rhl inducible construct (K1073035)  in Top10F’ cells. The sequence was confirmed.<br>
+
<img alt="August 10" src="https://static.igem.org/mediawiki/parts/thumb/e/e4/Braunschweig2013_Top10_pSB1C3_K1073035.jpg/500px-Braunschweig2013_Top10_pSB1C3_K1073035.jpg" width="350" vspace="20" align="right"/>Some of the liquid culture was used for prepping and sequencing the Prhl inducible construct in <i>E. coli</i> Top10F' cells. The sequence was confirmed.<br>
-
We measured our first successful growth curve showing the difference in growth between induced and non-induced versions of the Rhl inducible construct (K1073035).</p>
+
We measured our first successful growth curve showing the difference in growth between induced and non-induced versions of the Prhl inducible construct. The eforRed expression cassette in <i>E. coli</i> Top10F' was miniprepped and glycerol stocks of this strain were made.
 +
The main cultures (induced and not induced) of the final PRhl inducible construct were inoculated to a start OD520 of 0.05 in 75 ml 2xYT containing ampicillin with cells of the pre-culture. In order to induce the expression of ampR N-3-butyryl homoserine lactone was added to a final concentration of 10 µM. Samples were taken at appropriate times depending on the growth phase until the induced culture reached the stationary phase. OD was determined at 520 nm to avoid absorptions by chromoproteins.
 +
<br>
 +
</div>
-
 
-
</div>
 
Line 771: Line 850:
     <h2><a href="#Week13">Week 13: August 11 - August 17, 2013</a></h2>
     <h2><a href="#Week13">Week 13: August 11 - August 17, 2013</a></h2>
     <p style=" margin-left:5px; margin-right:5px;">
     <p style=" margin-left:5px; margin-right:5px;">
-
This week was dominated by testing our constructs in continuous as well as in batch culture for inducibility and regulation. Unregulated growth in chloramphenicol containing medium and regulated growth in ampicillin containing medium was tested in continuous culture. The growth kinetics observed for our Rhl regulated could be verified in a second growth curve for induced and uninduced growth. Further we received <i>E. coli</i> JM109 strains containing a reporter plasmid expressing <i>luxCDABE</i> in the presence of specific activating  N-acyl homoserine lactones (AHLs) (Winsen, M.K. et al. 1998) resulting in bioluminescence of these reporter strains. We will be using these strains in order to verify the production of the specific homoserine lactones by our constructs.<br> </p>
+
This week was dominated by testing our constructs in continuous as well as in batch culture for inducibility and regulation. Unregulated growth in chloramphenicol containing medium and regulated growth in ampicillin containing medium was tested in continuous culture. The growth kinetics observed for our Rhl regulated could be verified in a second growth curve for induced and uninduced growth. Further we received <i>E. coli</i> JM109 strains containing a reporter plasmid expressing <i>luxCDABE</i> in the presence of specific activating  N-acyl homoserine lactones (AHSLs) (Winsen, M.K. et al. 1998) resulting in bioluminescence of these reporter strains. We will be using these strains in order to verify the production of the specific homoserine lactones by our constructs.<br> </p>
Line 788: Line 867:
<b>Investigators: Kerstin, Laura </b><br>
<b>Investigators: Kerstin, Laura </b><br>
Pre-cultures of chromoprotein constructs were mixed in one main culture in order to see how they behave during cultivation over several hours. OD<sub>520</sub> of pre-cultures was measured in order to inoculate the main culture with  33% of each strain to a final OD<sub>520</sub>=0.3. For the main culture, 25 ml 2xYT containing chloramphenicol were inoculated with the three different strains and grown at 37°C and 250 rpm in a non-baffled flask. Samples from the culture were taken at several time points, diluted and plated on 2xYT agar-plates containing chloramphenicol. Agar plates were incubated at 37°C over night.<br>
Pre-cultures of chromoprotein constructs were mixed in one main culture in order to see how they behave during cultivation over several hours. OD<sub>520</sub> of pre-cultures was measured in order to inoculate the main culture with  33% of each strain to a final OD<sub>520</sub>=0.3. For the main culture, 25 ml 2xYT containing chloramphenicol were inoculated with the three different strains and grown at 37°C and 250 rpm in a non-baffled flask. Samples from the culture were taken at several time points, diluted and plated on 2xYT agar-plates containing chloramphenicol. Agar plates were incubated at 37°C over night.<br>
 +
Today we also observed our cells containing the chromoprotein expression cassette under the fluorescence microscope.
 +
<img alt="microscope" src="https://static.igem.org/mediawiki/2013/0/09/Braunschweig_Lab_Week13_microscope.jpg" height="200px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
During the day we noticed that the 2xYT medium used for the pre-cultures yesterday showed contamination. Thus, there is a high possibility  of contamination in the pre-culture as well as in the main culture. Therefore we decided to repeat the experiment. New pre-cultures of the three chromoprotein expression cassettes where inoculated in 50 ml 2xYT containing chloramphenicol directly from -80°C.<br>
During the day we noticed that the 2xYT medium used for the pre-cultures yesterday showed contamination. Thus, there is a high possibility  of contamination in the pre-culture as well as in the main culture. Therefore we decided to repeat the experiment. New pre-cultures of the three chromoprotein expression cassettes where inoculated in 50 ml 2xYT containing chloramphenicol directly from -80°C.<br>
In order to have our constructs available in different <i>E. coli</i> strains for the fluorescence microscopy experiments, the eforRed expression cassette was transformed into <i>E. coli</i> Top10F' by electroporation. Transformed cells were plated on 2xYT agar containing chloramphenicol and incubated over night at 37°C.<br>
In order to have our constructs available in different <i>E. coli</i> strains for the fluorescence microscopy experiments, the eforRed expression cassette was transformed into <i>E. coli</i> Top10F' by electroporation. Transformed cells were plated on 2xYT agar containing chloramphenicol and incubated over night at 37°C.<br>
-
A continuous cultivation of the P<sub>Rhl</sub> inducible in <i>E. coli</i> Top10F' was prepared, including preparation of pre-cultures of our inducible construct in 50 ml 2xYT containing chloramphenicol and grown at 37°C and 250 rpm over night.<br>
+
A continuous cultivation of the Prhl inducible in <i>E. coli</i> Top10F' was prepared, including preparation of pre-cultures of our inducible construct in 50 ml 2xYT containing chloramphenicol and grown at 37°C and 250 rpm over night.<br>
  </p>
  </p>
Line 815: Line 896:
The reporter strains for the Las and Rhl systems (<i>E. coli</i> JM109 pSB1075 and <i>E. coli</i> JM109 pSB406 respectively) arrived today. Liquid cultures in 2xYT containing ampicillin were inoculated and grown at 37°C and 250 rpm overnight.<br>  
The reporter strains for the Las and Rhl systems (<i>E. coli</i> JM109 pSB1075 and <i>E. coli</i> JM109 pSB406 respectively) arrived today. Liquid cultures in 2xYT containing ampicillin were inoculated and grown at 37°C and 250 rpm overnight.<br>  
-
Pre-cultures of <i>E. coli</i> Top10F' containing final P<sub>Rhl</sub> inducible construct and <i>E. coli</i> XL1 Blue MRF' containing final P<sub>Las</sub> inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.<br></p>  
+
Pre-cultures of <i>E. coli</i> Top10F' containing final Prhl inducible construct and <i>E. coli</i> XL1 Blue MRF' containing final Plas inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.<br></p>  
Line 825: Line 906:
Pre-culture of erforRed expression cassette in <i>E. coli</i> Top10F' in 50 ml 2xYT containing chloramphenicol was inoculated from the  agar plate and grown at 37°C and 250 rpm overnight.<br>
Pre-culture of erforRed expression cassette in <i>E. coli</i> Top10F' in 50 ml 2xYT containing chloramphenicol was inoculated from the  agar plate and grown at 37°C and 250 rpm overnight.<br>
-
For the reproduction of the growth curve a pre-culture of the P<sub>Rhl</sub> inducible construct in <i>E. coli</i> Top10F' in 30 mL 2xYT containing chloramphenicol and incubated at 37°C overnight. <br>
+
For the reproduction of the growth curve a pre-culture of the Prhl inducible construct in <i>E. coli</i> Top10F' in 30 mL 2xYT containing chloramphenicol and incubated at 37°C overnight. <br>
To test the production of homoserine lactones (HSL) by our final constructs we prepared a pre-culture of each reporter strain in 30 ml 2xYT containing ampicillin and incubated them overnight at 37°C and 250 rpm. We also made glycerol cell stocks of the reporter strains for further use.<br>
To test the production of homoserine lactones (HSL) by our final constructs we prepared a pre-culture of each reporter strain in 30 ml 2xYT containing ampicillin and incubated them overnight at 37°C and 250 rpm. We also made glycerol cell stocks of the reporter strains for further use.<br>
Line 841: Line 922:
The eforRed expression cassette in <i>E. Coli</i> TOP10F’ was miniprepped and glycerol stocks of this strain were made.<br>
The eforRed expression cassette in <i>E. Coli</i> TOP10F’ was miniprepped and glycerol stocks of this strain were made.<br>
-
The main cultures (induced and not induced) of the final P<sub>Rhl</sub> inducible construct were inoculated to a start OD<sub>520</sub> of 0.05 in 75 ml 2xYT containing ampicillin with cells of the pre-culture. In order to induce the expression of <i>ampR</i> N-3-buturyl homoserine lactone was added to a final concentration of 10 µM. Samples were taken at appropriate times depending on the growth phase until the induced culture reached the stationary phase. OD was determined at 520 nm to avoid absorptions by chromoproteins.<br>
+
The main cultures (induced and not induced) of the final Prhl inducible construct were inoculated to a start OD<sub>520</sub> of 0.05 in 75 ml 2xYT containing ampicillin with cells of the pre-culture. In order to induce the expression of <i>ampR</i> N-3-butyryl homoserine lactone was added to a final concentration of 10 µM. Samples were taken at appropriate times depending on the growth phase until the induced culture reached the stationary phase. OD was determined at 520 nm to avoid absorptions by chromoproteins.<br>
To verify production of HSLs by our constructs the pre-cultures containing the finale constructs as well as the negative controls were centrifuged for 10 min at 6000 rpm and 4°C. Supernatant was transferred to a new Falcon tube and sterilized by filtration. <br>
To verify production of HSLs by our constructs the pre-cultures containing the finale constructs as well as the negative controls were centrifuged for 10 min at 6000 rpm and 4°C. Supernatant was transferred to a new Falcon tube and sterilized by filtration. <br>
Dilution series of the supernatants and the synthetic HSLs as standards were pipetted in 96-well microtiter plates. Wells were inoculated with the corresponding reporter strain and grown for 3 h at 37°C. Bioluminescence produced by the <i>luxCDABE</i> of the reporter strains was detected by a microplate reader. We were able to show that our constructs produced the specific HSLs. However due to the high background especially in the N-3-oxododecanoyl-HSL producing strain we might need to modify the experimental layout in order to get a stronger signal.<br><br><br></p>
Dilution series of the supernatants and the synthetic HSLs as standards were pipetted in 96-well microtiter plates. Wells were inoculated with the corresponding reporter strain and grown for 3 h at 37°C. Bioluminescence produced by the <i>luxCDABE</i> of the reporter strains was detected by a microplate reader. We were able to show that our constructs produced the specific HSLs. However due to the high background especially in the N-3-oxododecanoyl-HSL producing strain we might need to modify the experimental layout in order to get a stronger signal.<br><br><br></p>
Line 853: Line 934:
     <h2><a href="#Week14">Week 14: August 18 - August 24, 2013</a></h2>
     <h2><a href="#Week14">Week 14: August 18 - August 24, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
The focus of this week’s work was the preparation of the final constructs in order to take pictures under the fluorescence microscope. Furthermore we started the second continuous bioreactor culture.</p>
+
<img alt="Chromoprotein expression" src="https://static.igem.org/mediawiki/2013/7/75/Braunschweig_Lab_Week14_continuous_cultivation.jpg" height="140px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>
 +
The focus of this week’s work was the preparation of the final constructs in order to take pictures under the fluorescence microscope. Furthermore we started the second continuous bioreactor culture.
 +
</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 860: Line 943:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kerstin, Kevin, Roman, Jan, Judith</b><br>
<b>Investigators: Laura, Kerstin, Kevin, Roman, Jan, Judith</b><br>
-
We made glycerin stocks of J23100-B0032-eforRed-cassette and the final constructs (K1073034 and K1073035) in different strains (Top10F’ and JM109). Furthermore we transformed J23100-B0032-aeBlue into strain JM109. The functionality of the final aeBlue-construct (K1073034) in strain JM109 was evaluated by growing it on media supplemented with ampicillin and the inducer N-oxodecanoyl homoserine lactone. The strain grew and developed a blue color. This observation led to the conclusion that the construct worked in JM109.<br>  
+
We made glycerol stocks of J23100-B0032-eforRed-cassette and the final inducible constructs in different strains (<i>E. coli</i> Top10 F' and <i>E. coli</i> JM109). Furthermore we transformed J23100-B0032-aeBlue into strain JM109. The functionality of the final Plas construct in strain <i>E. coli</i> JM109 was evaluated by growing it on media supplemented with ampicillin and the inducer N-3-oxododecanoyl homoserine lactone. The strain grew and developed a blue color. This observation led to the conclusion that the construct worked in<i>E. coli</i> JM109.<br>  
-
Furthermore we miniprepped the final aeBlue-construct (K1073034) in JM109 and revised the sequencing results of the final eforRed-construct in Top10F’. The final eforRed construct (K1073035) was sequence verified.</p>
+
Furthermore we miniprepped the final Plas contruct in <i>E. coli</i> JM109 and revised the sequencing results of the final eforRed-construct in <i>E. coli</i> Top10 F’. The final Prhl construct was sequence verified.<br>
 +
We also conducted regulated and unregulated continuous bioreactor cultivations of mixed cultures of <i>E. coli</i> TOP10F'bearing final Prhl construct and <i>E. coli</i> JM109 containing the final Plas construct. The cultures were inoculated with a 70 % : 30 % ratio of <i>E. coli</i> Top10F' (Prhl construct)/<i>E. coli</i>(Plas construct) and samples were taken every hour. In order to determine the ratios of the strains during the cultivation, the samples were spread out on agar plates and incubated at 37°C. The cultivation was stopped after 25 h. </p>
 +
 
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 868: Line 953:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kerstin</b><br>
<b>Investigators: Laura, Kerstin</b><br>
-
The final aeBlue-construct (K1073034) in JM109 was prepared for sequencing. Additionally we inoculated cultures of TOP10F’ carrying J23100-B0032-aeBlue, J23100-B0032-eforRed and the final aeBlue (K1073034)- and eforRed (K1073035) constructs, respectively, with and without the corresponding inducer in order to gain material for fluorescence microscopy the next day.</p>
+
The final Plas construct in <i>E. coli</i> JM109 was prepared for sequencing. Additionally we inoculated cultures of <i>E. coli</i> Top10F' carrying J23100-B0032-aeBlue, J23100-B0032-eforRed and the final Plas and Prhl constructs, respectively, with and without the corresponding inducer in order to gain material for fluorescence microscopy experiments the next day.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 875: Line 960:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Kerstin</b><br>
<b>Investigators: Kerstin</b><br>
-
Glycerin stocks of the J23100-0032-aeBlue construct in TOP10F’ were made. Today we also visited the DSMZ to take fluorescence microscopy pictures of bacteria bearing the J23100-0032-aeBlue, J23100-0032-eforRed and the final aeBlue (K1073034) and eforRed (K1073035) constructs. Unfortunately due to wrong settings the obtained pictures were unusable.</p>
+
Glycerol stocks of the J23100-0032-aeBlue construct in <i>E. coli</i> Top10F' were made. Today we also visited the DSMZ to take fluorescence microscopy pictures of bacteria bearing the J23100-0032-aeBlue, J23100-0032-eforRed and the final Plas and Prhl) constructs. Unfortunately due to problems with the autofocus of the mircroscope the obtained pictures were unusable.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 882: Line 967:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kevin, Jan, Roman, Judith</b><br>
<b>Investigators: Laura, Kevin, Jan, Roman, Judith</b><br>
-
We made Glycerin stocks of the final constructs TOP10F’::K1073034 and JM109::K1073034 from agar plates of the reactor cultivation.<br>  
+
We made glycerol stocks of the final Prhl (<i>E. coli</i> Top10F'::K1073035) and Plas (<i>E. coli</i> JM109::K1073034) constructs from agar plates of the reactor cultivation.<br>  
-
Furthermore 10 mM stock solutions of the Rhl- and the Las-Autoinducer (1.7 mg N-butyryl  homoserine lactone + 1 ml DMSO and 2.8 mg N-3-oxododecanoyl  homoserinelactone +  933 ul DMSO, respectively) were prepared.<br>
+
Furthermore 10 mM stock solutions of the homoserine lactones (autoinducers) of the rhl and las quorum sensing system (1.7 mg N-butyryl  homoserine lactone + 1 ml DMSO and 2.8 mg N-3-oxododecanoyl  homoserine lactone +  933 µl DMSO, respectively) were prepared.<br>
Additionally we repeated the continuous bioreactor cultivation we conducted Monday.</p>
Additionally we repeated the continuous bioreactor cultivation we conducted Monday.</p>
Line 891: Line 976:
     <h2><a href="#Week15">Week 15: August 25 - August 31, 2013</a></h2>
     <h2><a href="#Week15">Week 15: August 25 - August 31, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
Week 15</p>
+
Preparation for exams kept us really busy so just a few experiments were done this week. We unsuccessfully tried to find the source of the mysterious white colonies, which we observed in samples taken from previous continuous cultivation experiments.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, August 27, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Kevin</b><br>
 +
<img alt="August 27" src="https://static.igem.org/mediawiki/2013/a/aa/Braunschweig_Lab_Journal_August_27.jpg" width="400" align="right" vspace="0" hspace="20"/> Today we checked one pink, one blue and six white colonies from a spread out sample that we took during our previous continuous cultivation for successful integration of our cloned vectors. This was primarily done to reveal the unknown source of white cultures on our agar plates. The blue colony and three of the white colonies were positive for integration of the final Plas construct. These colonies later turned blue. For some reason, all colonies showed integration of final Prhl construct, including the blue control.<br>
 +
Furthermore, we inoculated liquid cultures of final Plas and final Prhl constructs in <i>E. coli</i> JM109 and <i>E. coli</i> Top10 F' cells and also the autoinducer detecting strains <i>E. coli</i> JM109 pSB1075 and <i>E. coli</i> JM109 pSB406 which are used to detect the production ofautoinducers by our constructs.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, August 28, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Kevin</b><br>
 +
<img alt="August 28" src="https://static.igem.org/mediawiki/2013/6/6e/Braunschweig_Lab_Journal_August_28.jpg" width="250" align="right" vspace="0" hspace="20"/>On Wednesday, we tried to resolve the puzzling results from the colony PCR that we performed on Tuesday, this time with different primer/annealing temperature/DNA polymerase combinations but with the same colonies. However, PCRs didn’t clarify the previous results. Using GoTaq polymerase, the red and the blue colony were positive for aeBlue amplification, while white colonies were negative. PCR with Q5 polymerase indicated surprising integration patterns. Unfortunately, extraction of these bands did not yield enough DNA for sequencing.</p>
 +
 
   </div>
   </div>
Line 908: Line 1,009:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan, Anna, Melanie</b><br>
<b>Investigators: Jan, Anna, Melanie</b><br>
-
We prepared pre-cultures of <i>E. Coli</i> JM109 carrying the final P<sub>Las</sub> construct for the growth curve experiments tomorrow. 2xYT medium containing chloramphenicol was inoculated with cells directely from glycerol stock and incubated at 37°C and 250 rpm over night.</p>
+
We prepared pre-cultures of <i>E. coli</i> JM109 carrying the final Plas construct for the growth curve experiments tomorrow. 2xYT medium containing chloramphenicol was inoculated with cells directely from glycerol stock and incubated at 37°C and 250 rpm over night.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 915: Line 1,016:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan, Anna, Melanie</b><br>
<b>Investigators: Jan, Anna, Melanie</b><br>
-
We conducted a cultivation experiment with the <i>E. Coli</i> JM109 bearing the final P<sub>Las</sub> construct to test the growth in presence and Absence of synthetic N-3-oxododecanoyl-HSL autoinducer added to the medium. Cultivation was carried out in four 500 mL non-baffled flasks with 75 mL 2xYT medium with ampicillin. In two flasks N-3-oxododecanoyl-HSL was added. Ideally  the flask without N-3-oxododecanoyl-HSL would not show any growth in the beginning until the antibiotic has been depleted. The N-3-oxododecanoyl-HSL in the other flask should induce the quorum sensing controlled ampicillin resistance. Unfortunately all cultures were growing equally fast from the start so the experiment was aborted.</p>
+
We conducted a cultivation experiment with the <i>E. coli</i> JM109 bearing the final Plas construct to test the growth in presence and absence of synthetic N-3-oxododecanoyl-HSL autoinducer added to the medium. Cultivation was carried out in four 500 mL non-baffled flasks with 75 mL 2xYT medium with Ampicillin. In two flasks N-3-oxododecanoyl-HSL was added. Ideally  the flask without N-3-oxododecanoyl-HSL would not show any growth in the beginning until the antibiotic has been depleted. The N-3-oxododecanoyl-HSL in the other flask should induce the quorum sensing controlled ampicillin resistance. Unfortunately all cultures were growing equally fast from the start so the experiment was aborted.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 922: Line 1,023:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan, Anna, Melanie</b><br>
<b>Investigators: Jan, Anna, Melanie</b><br>
-
We repeated the growth curve experiment with our <i>E. coli</i> JM109 bearing final P<sub>Las</sub> to see if the unexpected growth was caused by a resistant contamination. Cultivation was again carried out in four 500 mL non-baffled flasks with 75 mL 2xYT medium with ampicillin. Again, in two out of the four flasks N-3-oxododecanoyl-HSL was added.  The result was the same as yesterday, all culture showed normal growth. We needed a new strategy for future experiments.</p>
+
We repeated the growth curve experiment with our <i>E. coli</i> JM109 bearing final Plas to see if the unexpected growth was caused by a resistant contamination. Cultivation was again carried out in four 500 mL non-baffled flasks with 75 mL 2xYT medium with ampicillin. Again, in two out of the four flasks N-3-oxododecanoyl-HSL was added.  The result was the same as yesterday, all culture showed normal growth. We needed a new strategy for future experiments.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 930: Line 1,031:
<b>Investigators: Jan, Anna, Melanie</b><br>
<b>Investigators: Jan, Anna, Melanie</b><br>
We figured that maybe our ampicillin resistance was too potent because even the basal expression allowed for normal growth in medium with antibiotic.<br>
We figured that maybe our ampicillin resistance was too potent because even the basal expression allowed for normal growth in medium with antibiotic.<br>
-
We prepared 5 mL liquid cultures of <i>E. coli</i> JM109 bearing final P<sub>Las</sub> and added varying amounts of a beta-lactamase inhibitor (clavulanic acid) to suppress the background expression. Tubes with 1 µg/µL to 100 µg/µL clavulanic acid showed no growth while tubes with 0.001 µg/µL to 0.1 µg/µL clavulanic acid showed normal growth.</p>  
+
We prepared 5 mL liquid cultures of <i>E. coli</i> JM109 bearing final Plas and added varying amounts of a beta-lactamase inhibitor (clavulanic acid) to suppress the background expression. Tubes with 1 µg/µL to 100 µg/µL clavulanic acid showed no growth while tubes with 0.001 µg/µL to 0.1 µg/µL clavulanic acid showed normal growth.</p>  
Line 938: Line 1,039:
     <h2><a href="#Week18">Week 18: September 15 - September 21, 2013</a></h2>
     <h2><a href="#Week18">Week 18: September 15 - September 21, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
This week we were happy to find a workaround for a big troublemaker: the background expression of β-lactamase in non-induced state. We determined the critical concentration of β-lactamase inhibitor clavulanic acid to be around 1 µg/ml. Furthermore, we directly applied it to experiments which previously were problematic because of the resistance to ampicillin under non-induced conditions.<br>
+
This week we were happy to find a workaround for a big troublemaker: the background expression of beta-lactamase in non-induced state. We determined the critical concentration of beta-lactamase inhibitor clavulanic acid to be around 1 µg/ml. Furthermore, we directly applied it to experiments which previously were problematic because of the resistance to ampicillin under non-induced conditions.<br>
-
Furthermore, we added our constructs to the iGEM Registry. Therefore our final contructs are from now on referred to as K1073034 and K1073035 for final P<sub>Las</sub> construct and final P<sub>Rhl</sub> construct respectively.
+
Furthermore, we added our constructs to the iGEM Registry. Therefore our final contructs are from now on referred to as <a href="http://parts.igem.org/Part:BBa_K1073034">K1073034</a> and <a href="http://parts.igem.org/Part:BBa_K1073035">K1073035</a> for final Plas construct and final Prhl construct respectively.
</p>
</p>
Line 947: Line 1,048:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan</b><br>
<b>Investigators: Jan</b><br>
-
This week started with a quite important experiment: Since we experienced background expression of beta-lactamase, our transformed bacteria were resistant on a low level to ampicillin, although cultivated under non-inducing conditions.  We prepared 5mL liquid cultures of JM109::K1073034 and added varying amounts of a beta-lactamase inhibitor (clavulanic acid) to suppress the background expression. Tubes with 1 µg/µL to 100 µg/µL clavulanic acid showed no growth while tubes with 0.001 µg/µL to 0.1 µg/µL clavulanic acid showed normal growth.</p>
+
<img alt="September 16" src="https://static.igem.org/mediawiki/2013/2/2f/Braunschweig_Lab_Journal_September_19.png" width="400" vspace="20" align="right"/>This week started with a quite important experiment: Since we experienced background expression of beta-lactamase, our transformed bacteria were resistant on a low level to ampicillin, although cultivated under non-inducing conditions.  We prepared 5 mL liquid cultures of <i>E. coli</i> JM109::K1073034 and added varying amounts of a beta-lactamase inhibitor (clavulanic acid) to suppress the background expression. Tubes with 1 µg/µL to 100 µg/µL clavulanic acid showed no growth while tubes with 0.001 µg/µL to 0.1 µg/µL clavulanic acid showed normal growth.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 955: Line 1,056:
<b>Investigators: Jan</b><br>
<b>Investigators: Jan</b><br>
On Wednesday, we repeated the experiment we did on Monday with a different scale of concentration steps to more precisely determine the best concentration of clavulanic acid for future experiments. Unfortunately, all samples showed growth so no further distinction could be made.<br>
On Wednesday, we repeated the experiment we did on Monday with a different scale of concentration steps to more precisely determine the best concentration of clavulanic acid for future experiments. Unfortunately, all samples showed growth so no further distinction could be made.<br>
-
Hence, we went ahead with the 1 µg/ml of clavulanic acid we determined on Monday to remove background expression of β-lactamase. We applied this information to a certain growth behavior of JM109 bacteria transformed with our final construct (K1073034). Therefore, we cultivated this strain in 2x YT media with ampicillin and clavulanic acid. Out of four cultures, only two contained the inducer necessary for successful induction of ampicillin resistance.</p>
+
Hence, we went ahead with the 1 µg/ml of clavulanic acid we determined on Monday to remove background expression of beta-lactamase. We applied this information to a certain growth behavior of <i>E. coli</i> JM109 bacteria transformed with our final construct (K1073034). Therefore, we cultivated this strain in 2x YT media with ampicillin and clavulanic acid. Out of four cultures, only two contained the inducer necessary for successful induction of ampicillin resistance.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 962: Line 1,063:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan</b><br>
<b>Investigators: Jan</b><br>
-
Liquid cultures of 2x YT media with ampicillin and 1 µg/ml clavulanic acid were inoculated at different ratios (based on OD<sub>520</sub>) of JM109::K1073034 and Top10F'::K1073035. Each culture was additionally performed with chloramphenicol instead of ampicillin as unregulated control. Unfortunately the concentration of clavulanic acid was too high and no growth was observed.</p>
+
<img alt="September 19" src="https://static.igem.org/mediawiki/parts/thumb/9/98/Braunschweig_2013_-_JM109_pSB1C3_K1073034.jpg/480px-Braunschweig_2013_-_JM109_pSB1C3_K1073034.jpg" width="400" vspace="20" align="right"/>Liquid cultures of 2x YT media with ampicillin and 1 µg/ml clavulanic acid were inoculated at different ratios (based on OD<sub>520</sub>) of <i>E. coli</i> JM109::K1073034 and <i>E. coli</i> Top10F'::K1073035. Each culture was additionally performed with chloramphenicol instead of ampicillin as unregulated control. Unfortunately the concentration of clavulanic acid was too high and no growth was observed.</p>
 +
 
  </div>
  </div>
Line 968: Line 1,070:
     <h2><a href="#Week19">Week 19: September 22 - September 28, 2013</a></h2>
     <h2><a href="#Week19">Week 19: September 22 - September 28, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
This week started with a continuous cultivation, which in contrast to earlier ones was performed with added beta-lactamase inhibitor (clavulanic acid). On Wednesday, we repeated last weeks experiment to investigate the ratio of bacterial growth if both strains (JM109::K1073034 and TOP10F’::K1073035) are cultivated together under different conditions and with varying inoculation ratios.</p>
+
<img alt="lab" src="https://static.igem.org/mediawiki/2013/d/d5/Braunschweig_Lab_Week19_crazy_at_the_lab.jpg" height="200px" align="left" vspace="0" hspace="10" style="margin-right:5px"/>This week started with the last continuous cultivation, which in contrast to earlier ones was performed with added beta-lactamase inhibitor (clavulanic acid). On Wednesday, we repeated last weeks experiment to investigate the ratio of bacterial growth if both strains (<i>E. coli</i> JM109::K1073034 and <i>E. coli</i> Top10F'::K1073035) are cultivated together under different conditions and with varying inoculation ratios. This was a really tough last week, no wounder that people going crazy at the lab.</p>
 +
 
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 975: Line 1,078:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan</b><br>
<b>Investigators: Jan</b><br>
-
Overnight cultures were inoculated for the continuous cultivation on Monday. Furthermore, we set up the reactors and made sure we are ready to start early next day.</p>
+
Overnight cultures of <i>E. coli</i> JM109::K1073035 and <i>E. coli</i> Top10F'::K1073035 were inoculated in 2xYT for the continuous cultivation on Monday. Furthermore, we set up the reactors and made sure we are ready to start early next day.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 982: Line 1,085:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan, Anna, Melanie, Kevin, Roman, Judith</b><br>
<b>Investigators: Jan, Anna, Melanie, Kevin, Roman, Judith</b><br>
-
This time we inoculated the reactors with a 70/30 ratio of JM109::K1073034/TOP10F’::K1073035 and cultivated for 22h under constant observation to make sure we didn’t miss potentially interesting growth behavior. Samples were taken every hour. After plating a diluted sample on agar plates with chloramphenicol, OD<sub>520</sub> was measured for monitoring the growth behavior. In comparison to earlier reactor cultivations, this time we added 5 µg/L clavulanic acid to the cultivation media (2xYT + either ampicillin in first reactor or chloramphenicol in second reactor) to suppress the background expression of beta-lactamase.</p>
+
This time we inoculated the reactors with a 70/30 ratio of <i>E. coli</i> JM109::K1073034/<i>E. coli</i> Top10F'::K1073035 and cultivated for 22h under constant observation to make sure we didn’t miss potentially interesting growth behavior. Samples were taken every hour. After plating a diluted sample on agar plates with chloramphenicol, OD<sub>520</sub> was measured for monitoring the growth behavior. In comparison to earlier reactor cultivations, this time we added 5 µg/L clavulanic acid to the cultivation media (2xYT + either ampicillin in first reactor or chloramphenicol in second reactor) to suppress the background expression of beta-lactamase.</p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
Line 989: Line 1,092:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Jan</b><br>
<b>Investigators: Jan</b><br>
-
We conducted another ratio test on Wednesday. Therefore 2xYT media with ampicillin and 0.01 µg/mL were inoculated with different ratios of <i>E. Coli</i> Top10F’::K1073035  and <i>E. Coli</i> JM109::K1073034 and cultivated for 14 hours. Additionally a control on chloramphenicol was cultivated. Unfortunately this time the clavulanic acid concentration was too low and the cells grew as if cultivated without clavulanic acid. </p>
+
We conducted another ratio test on Wednesday. Therefore 2xYT media with ampicillin and 0.01 µg/mL were inoculated with different ratios of <i>E. coli</i> Top10F’::K1073035  and <i>E. coli</i> JM109::K1073034 and cultivated for 14 hours. Additionally a control on chloramphenicol was cultivated. Unfortunately this time the clavulanic acid concentration was too low and the cells grew as if cultivated without clavulanic acid. </p>
   </div>
   </div>
Line 996: Line 1,099:
     <h2><a href="#Week20">Week 20: September 29 - October 4, 2013</a></h2>
     <h2><a href="#Week20">Week 20: September 29 - October 4, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
Week 20</p>
+
This week we spent time evaluating our last continuous cultivation of mixed <i>E. coli</i> JM109 and Top10F' containing our final constructs. Other than that we prepared our data and ourselves for the upcoming regional jamboree.</p>
   </div>
   </div>
Line 1,012: Line 1,115:
<h1>Our sponsors</h1></p>
<h1>Our sponsors</h1></p>
<img alt="linie rot 8pix hoch" src="https://static.igem.org/mediawiki/2013/0/07/Team_Braunschweig_Red_line.jpg" width="890" height="1" />
<img alt="linie rot 8pix hoch" src="https://static.igem.org/mediawiki/2013/0/07/Team_Braunschweig_Red_line.jpg" width="890" height="1" />
-
<img src="https://static.igem.org/mediawiki/2013/7/73/SponsorenLogosBS210712.png" width="875px" />
+
<img src="https://static.igem.org/mediawiki/2013/9/9e/SponsorenBS.png" width="875px" />
</div>
</div>
</html>
</html>

Latest revision as of 13:15, 27 October 2013

Labjournal

linie rot 8pix hoch

Braunschweig Labbook This is the documentation of our lab work. Achievements of each week are summerized followed by a daily discription of our experiments.

An overview on how we approached this project can be found under Approach. For detailed protocols of certain procedures please refer to Protocols. Attributions are given for each day, however please check our
Attributions section for efforts beyond the lab work.


grey line

Our sponsors

linie rot 8pix hoch